PERBEDAAN FUNGSI PARU PADA PENDERITA SINDROMA METABOLIK DAN TANPA SINDROMA METABOLIK
Metabolic syndrome is a combination of central obesity, elevated blood pressure, impaired glucose metabolism , and dyslipidemia. Prevalence is increasing worldwide. Several previous studies indicate that there is a difference controversy lung function and metabolic syndrome without metabolic syndrom...
Saved in:
Main Authors: | , |
---|---|
Format: | Theses and Dissertations NonPeerReviewed |
Published: |
[Yogyakarta] : Universitas Gadjah Mada
2013
|
Subjects: | |
Online Access: | https://repository.ugm.ac.id/126117/ http://etd.ugm.ac.id/index.php?mod=penelitian_detail&sub=PenelitianDetail&act=view&typ=html&buku_id=66312 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universitas Gadjah Mada |
id |
id-ugm-repo.126117 |
---|---|
record_format |
dspace |
spelling |
id-ugm-repo.1261172016-03-04T08:43:56Z https://repository.ugm.ac.id/126117/ PERBEDAAN FUNGSI PARU PADA PENDERITA SINDROMA METABOLIK DAN TANPA SINDROMA METABOLIK , TRI SETIANA KUSUMADEWI , dr. Luthfan Budi Purnomo, SpPD-KEMD ETD Metabolic syndrome is a combination of central obesity, elevated blood pressure, impaired glucose metabolism , and dyslipidemia. Prevalence is increasing worldwide. Several previous studies indicate that there is a difference controversy lung function and metabolic syndrome without metabolic syndrome . This study aims to determine whether the patient has the metabolic syndrome FEV1 percent predicted and FVC percent predicted lower than the normal population. The study design is a cross-sectional study. Subjects were patients with metabolic syndrome and without metabolic syndrome who meet the inclusion and exclusion criteria. There were 98 samples of the study with a mean age of 42.74 ± 9.14. Metabolic syndrome 48 people, and 48 healthy people as controls . On FVC percent predicted in the metabolic syndrome and without metabolic syndrome 99.27 ± 20.35 vs. 116.22 ± 20.67 ( p < 0.001 ), and FEV 1 was 116.05 ± 23.77 vs 130.06 ± 20.78 (p = 0.03). Patients with metabolic syndrome, 16.7% had a FEV1 < 80 % predicted that showed no decline in lung function type of obstruction , and 22.67 % of patients with metabolic syndrome have a FVC < 80 % predicted, indicating a decline in lung function of type of restriction. [Yogyakarta] : Universitas Gadjah Mada 2013 Thesis NonPeerReviewed , TRI SETIANA KUSUMADEWI and , dr. Luthfan Budi Purnomo, SpPD-KEMD (2013) PERBEDAAN FUNGSI PARU PADA PENDERITA SINDROMA METABOLIK DAN TANPA SINDROMA METABOLIK. UNSPECIFIED thesis, UNSPECIFIED. http://etd.ugm.ac.id/index.php?mod=penelitian_detail&sub=PenelitianDetail&act=view&typ=html&buku_id=66312 |
institution |
Universitas Gadjah Mada |
building |
UGM Library |
country |
Indonesia |
collection |
Repository Civitas UGM |
topic |
ETD |
spellingShingle |
ETD , TRI SETIANA KUSUMADEWI , dr. Luthfan Budi Purnomo, SpPD-KEMD PERBEDAAN FUNGSI PARU PADA PENDERITA SINDROMA METABOLIK DAN TANPA SINDROMA METABOLIK |
description |
Metabolic syndrome is a combination of central obesity, elevated blood pressure,
impaired glucose metabolism , and dyslipidemia. Prevalence is increasing worldwide.
Several previous studies indicate that there is a difference controversy lung function
and metabolic syndrome without metabolic syndrome .
This study aims to determine whether the patient has the metabolic syndrome FEV1
percent predicted and FVC percent predicted lower than the normal population. The
study design is a cross-sectional study. Subjects were patients with metabolic
syndrome and without metabolic syndrome who meet the inclusion and exclusion
criteria.
There were 98 samples of the study with a mean age of 42.74 ± 9.14. Metabolic
syndrome 48 people, and 48 healthy people as controls . On FVC percent predicted
in the metabolic syndrome and without metabolic syndrome 99.27 ± 20.35 vs. 116.22
± 20.67 ( p < 0.001 ), and FEV 1 was 116.05 ± 23.77 vs 130.06 ± 20.78 (p = 0.03).
Patients with metabolic syndrome, 16.7% had a FEV1 < 80 % predicted that showed
no decline in lung function type of obstruction , and 22.67 % of patients with
metabolic syndrome have a FVC < 80 % predicted, indicating a decline in lung
function of type of restriction. |
format |
Theses and Dissertations NonPeerReviewed |
author |
, TRI SETIANA KUSUMADEWI , dr. Luthfan Budi Purnomo, SpPD-KEMD |
author_facet |
, TRI SETIANA KUSUMADEWI , dr. Luthfan Budi Purnomo, SpPD-KEMD |
author_sort |
, TRI SETIANA KUSUMADEWI |
title |
PERBEDAAN FUNGSI PARU PADA PENDERITA SINDROMA
METABOLIK DAN TANPA SINDROMA METABOLIK |
title_short |
PERBEDAAN FUNGSI PARU PADA PENDERITA SINDROMA
METABOLIK DAN TANPA SINDROMA METABOLIK |
title_full |
PERBEDAAN FUNGSI PARU PADA PENDERITA SINDROMA
METABOLIK DAN TANPA SINDROMA METABOLIK |
title_fullStr |
PERBEDAAN FUNGSI PARU PADA PENDERITA SINDROMA
METABOLIK DAN TANPA SINDROMA METABOLIK |
title_full_unstemmed |
PERBEDAAN FUNGSI PARU PADA PENDERITA SINDROMA
METABOLIK DAN TANPA SINDROMA METABOLIK |
title_sort |
perbedaan fungsi paru pada penderita sindroma
metabolik dan tanpa sindroma metabolik |
publisher |
[Yogyakarta] : Universitas Gadjah Mada |
publishDate |
2013 |
url |
https://repository.ugm.ac.id/126117/ http://etd.ugm.ac.id/index.php?mod=penelitian_detail&sub=PenelitianDetail&act=view&typ=html&buku_id=66312 |
_version_ |
1681232380481765376 |